EC
KRON

EcoR1 Capital’s Kronos Bio KRON Stock Holding History

EcoR1 Capital’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-326,780
Closed -$562K – 57
2023
Q2 		$562K Hold
326,780
– – 0.01% 51
2023
Q1 		$477K Hold
326,780
– – 0.02% 53
2022
Q4 		$529K Hold
326,780
– – 0.02% 63
2022
Q3 		$1.09M Hold
326,780
– – 0.03% 65
2022
Q2 		$1.19M Hold
326,780
– – 0.04% 69
2022
Q1 		$2.36M Sell
326,780
-60,577
-16% -$517K 0.07% 60
2021
Q4 		$5.26M Hold
387,357
– – 0.17% 47
2021
Q3 		$8.12M Hold
387,357
– – 0.28% 37
2021
Q2 		$9.28M Hold
387,357
– – 0.35% 34
2021
Q1 		$11.3M Hold
387,357
– – 0.5% 28
2020
Q4 		$11.6M Buy
+387,357
New +$12.2M 0.62% 26

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital's KRON Position: Q3 2023 in Review

EcoR1 Capital sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 326,780 shares — an estimated $562K sold.

EcoR1 Capital first reported a position in KRON in Q4 2020 and held it in 11 quarters. The position peaked at $11.6M in Q4 2020. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • EcoR1 Capital reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • EcoR1 Capital sold 326,780 Kronos Bio shares in Q3 2023, an estimated $562K.
  • EcoR1 Capital first reported a position in Kronos Bio in Q4 2020 and held it in 11 quarters.
  • EcoR1 Capital's Kronos Bio position peaked at $11.6M in Q4 2020.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on EcoR1 Capital's 13F filing for Q3 2023, filed 14 Nov 2023.